Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries

<p><strong>Background</strong> The amplification of <i>GTP cyclohydrolase 1 (pfgch1)</i> in <i>Plasmodium falciparum</i> has been linked to the upregulation of the <i>pfdhfr</i> and <i>pfdhps</i> genes associated with resistance to th...

Bibliografski detalji
Glavni autori:	Srisutham, S, Madmanee, W, Kouhathong, J, Sutawong, K, Tripura, R, Peto, TJ, van der Pluijm, RW, Callery, JJ, Dysoley, L, Mayxay, M, Newton, PN, Pongvongsa, T, Hongvanthong, B, Day, NPJ, White, NJ, Dondorp, AM, Imwong, M
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2022

Slični predmeti

Ten-year persistence and evolution of Plasmodium falciparum antifolate and anti-sulfonamide resistance markers pfdhfr and pfdhps in three Asian countries.
od: Suttipat Srisutham, i dr.
Izdano: (2022-01-01)

Evaluation of prevalence's of <it>pfdhfr </it>and <it>pfdhps </it>mutations in Angola
od: Figueiredo Paula, i dr.
Izdano: (2011-02-01)

Prevalence of <it>pfmdr1</it>, <it>pfcrt</it>, <it>pfdhfr </it>and <it>pfdhps </it>mutations associated with drug resistance, in Luanda, Angola
od: Varandas Luís, i dr.
Izdano: (2008-11-01)

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso
od: Francis Emmanuel Towanou Bohissou, i dr.
Izdano: (2024-10-01)

Single Nucleotide Polymorphisms of Pfdhfr and Pfdhps Genes: Implications for Malaria Prophylactic Strategies in Maiduguri, Northeast Nigeria
od: Sulayman Tunde Balogun, i dr.
Izdano: (2021-01-01)

Polymorphisms in K13, pfcrt, pfmdr1, pfdhfr, and pfdhps in parasites isolated from symptomatic malaria patients in Burkina Faso
od: Somé Anyirékun Fabrice, i dr.
Izdano: (2016-01-01)

Increased prevalence of the <it>pfdhfr/phdhps </it>quintuple mutant and rapid emergence of <it>pfdhps </it>resistance mutations at codons 581 and 613 in Kisumu, Kenya
od: Prigge Sean T, i dr.
Izdano: (2010-11-01)

Antimalarial drug resistance in the Central and Adamawa regions of Cameroon: Prevalence of mutations in P. falciparum crt, Pfmdr1, Pfdhfr and Pfdhps genes.
od: Aline Gaelle Bouopda Tuedom, i dr.
Izdano: (2021-01-01)

High prevalence of Pfdhfr–Pfdhps quadruple mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea
od: Tingting Jiang, i dr.
Izdano: (2019-03-01)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
od: Sugaram, R, i dr.
Izdano: (2020)

Prevalence of Mutations in the <i>Pfdhfr</i>, <i>Pfdhps,</i> and <i>Pfmdr1</i> Genes of Malarial Parasites Isolated from Symptomatic Patients in Dogondoutchi, Niger
od: Ibrahima Issa, i dr.
Izdano: (2022-07-01)

Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant Pfdhfr-Pfdhps Alleles
od: Xiaoxiao Wang, i dr.
Izdano: (2022-10-01)

Occurrence of septuple and elevated Pfdhfr-Pfdhps quintuple mutations in a general population threatens the use of sulfadoxine-pyrimethamine for malaria prevention during pregnancy in eastern-coast of Tanzania
od: George M. Bwire, i dr.
Izdano: (2020-07-01)

Molecular Determinants of Sulfadoxine-Pyrimethamine Resistance in Plasmodium falciparum Isolates from Central Africa between 2016 and 2021: Wide Geographic Spread of Highly Mutated Pfdhfr and Pfdhps Alleles
od: Xiaoxiao Wang, i dr.
Izdano: (2022-10-01)

Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine–pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy
od: Aymen M. Madkhali, i dr.
Izdano: (2020-12-01)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
od: Rakmark, K, i dr.
Izdano: (2020)

Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
od: Awab, G, i dr.
Izdano: (2013)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
od: van der Pluijm, RW, i dr.
Izdano: (2022)

Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
od: Kasama Rakmark, i dr.
Izdano: (2020-07-01)

Evolution of multidrug resistance in Plasmodium falciparum: A longitudinal study of genetic resistance markers in the Greater Mekong subregion
od: Imwong, M, i dr.
Izdano: (2021)

Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
od: Karema, C, i dr.
Izdano: (2010)

Molecular characterization of Plasmodium falciparum antifolate resistance markers in Thailand between 2008 and 2016
od: Rungniran Sugaram, i dr.
Izdano: (2020-03-01)

Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax.
od: Leartsakulpanich, U, i dr.
Izdano: (2002)

Folates and antifolates in rheumatoid arthritis
od: Jansen Gerrit, i dr.
Izdano: (2013-06-01)

Acetylenic antifolates as anticancer agents
od: Önen Bayram Filiz Esra, i dr.
Izdano: (2015-09-01)

Advancing artemisinin resistance monitoring using a high sensitivity ddPCR assay for Pfkelch13 mutation detection in Asia
od: Srisutham, S, i dr.
Izdano: (2025)

ANTIFOLATES FOR CANCER CHEMOTHERAPY. PART I
od: V. A. Bacherikov
Izdano: (2014-11-01)

Village malaria workers for the community-based management of vivax malaria
od: Adhikari, B, i dr.
Izdano: (2022)

Accounting for aetiology: can regional surveillance data alongside host biomarker-guided antibiotic therapy improve treatment of febrile illness in remote settings?
od: Chandna, A, i dr.
Izdano: (2019)

Theoretical Investigation of the Enantioselective Complexations between pfDHFR and Cycloguanil Derivatives
od: Suriyawut Kulatee, i dr.
Izdano: (2017-11-01)

Structural basis of antifolate recognition and transport by PCFT
od: Parker, JL, i dr.
Izdano: (2021)

ANTIFOLATES FOR ANTICANCER CHEMOTHERAPY. PART IІ
od: V. A. Bacherikov
Izdano: (2015-01-01)

Type 2 antifolates in the chemotherapy of falciparum malaria
od: Delfino Reinaldo T., i dr.
Izdano: (2002-01-01)

The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong Subregion: a molecular epidemiology observational study
od: Imwong, M, i dr.
Izdano: (2017)

Efficacy of artemether-lumefantrine, the nationally-recommended artemisinin combination for the treatment of uncomplicated falciparum malaria, in southern Laos.
od: Mayxay, M, i dr.
Izdano: (2012)

Measurement of gene amplifications related to drug resistance in Plasmodium falciparum using droplet digital PCR
od: Srisutham, S, i dr.
Izdano: (2021)

Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus.
od: Siyu Wang, i dr.
Izdano: (2022-02-01)

Village malaria workers for the community-based management of vivax malaria
od: Bipin Adhikari, i dr.
Izdano: (2023-02-01)

Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
od: Mukaka, M, i dr.
Izdano: (2021)

Molecular identification of pfcytb, pfdhfr, and pvmrp1 mutations in imported malaria cases in Chile
od: Alan Oyarce, i dr.
Izdano: (2025-01-01)